Alina Chwist

Learn More
OBJECTIVE Chemerin and vaspin are new adipokines which may modulate inflammatory response and insulin sensitivity in non-alcoholic fatty liver disease (NAFLD). The aims of this study were to assess: (1) circulating levels of chemerin and vaspin and their association with liver histology and markers of liver injury in NAFLD patients; and (2) the relationship(More)
BACKGROUND Nonalcoholic fatty liver disease (NAFLD) includes a wide spectrum of liver diseases, ranging from pure steatosis to nonalcoholic steatohepatitis (NASH), and eventually to liver cirrhosis with its complications. Identifying advanced fibrosis in patients is crucial to evaluating prognosis and possible therapeutic intervention. A novel, simple, and(More)
Corticosteroids are used widely to treat many types of disease. In general, these drugs are considered safe for the liver; however, recent reports have demonstrated that high-dose methylprednisolone (MT) may cause severe liver injury. Here, we report a case of a 24-year-old female who was given pulsed MT therapy for multiple sclerosis. MT induced icteric(More)
INTRODUCTION Histopathological risk factors for end-stage liver failure in patients with nonalcoholic fatty liver disease (NAFLD) include nonalcoholic steatohepatitis (NASH) and advanced liver fibrosis. There is a need for noninvasive diagnostic methods for these 2 conditions. OBJECTIVES The aim of this study was to investigate new laboratory variables(More)
303 3 consecutive sessions of endoscopic rubber band‐ ing. A liver ultrasound (Siemens Acuson X300, Siemens Medical Solutions, Inc, Malvern, Penn‐ sylvania, United States) showed a subcapsular tu‐ mor with mixed echogenicity and a diameter of 2.5 cm, localized in segment 6 (FIGURE 1A). Further diagnostic workup with color Doppler ultrasound showed a(More)
  • 1